The Recall Desk
ModerateFDA (Drugs)·D-0155-2018·Announced 2018-01-17

Solco Healthcare Recalls Gabapentin Tablets Due to Labeling Error

Solco Healthcare is recalling Gabapentin 800 mg tablets because some bottles contain 600 mg tablets. The error affects product distributed in Mason, Ohio.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score (2) when no specific hospitalizations or severe injuries are reported in the source text, and the hazard is a labeling mix-up.

Plain-English summary

Solco Healthcare US, LLC is recalling Gabapentin Tablets, USP, 800 mg, 500-count, NDC 43547-0333-50, Lot # 7700656A. The recall is due to a labeling error where some bottles labeled as containing 800 mg tablets actually contain 600 mg tablets.

The affected product was distributed in Mason, Ohio. The recall is classified as Class II by the FDA, indicating a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.

Patients and healthcare providers should check their inventory for the specific lot number and NDC listed above. If the product is found, it should be quarantined and returned to the distributor or manufacturer for credit.

The recalled product

Product
Gabapentin Tablets, USP, 800 mg, 500-count, Rx only, Made in India, PONDRUGS/16 134193, Distributed by: Solco Healthcare US, LLC, Cranbury, NJ, 08512, USA. NDC 43547-0333-50

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot # 7700656A

Distribution

Distribution scope not specified by the agency.